Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Biotech big guns are buying up the minnows
Health & Biotech
My bank balance is bigger than yours: biotech quarterlies
News
New Zealand gave Aussie investors 16-bagger Xero; which other Kiwi companies call the ASX home?
Health & Biotech
Cancer Wars Part 2: These are the ASX small cap diagnostics plays that want to conquer cancer
Health & Biotech
Health: Alterity gets orphan status for its MSA drug
Health & Biotech
Health might be another overnight success in 2020
Health & Biotech
Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?
Stockhead TV
VIDEO: 90 Seconds With… Ralph Highnam, Volpara Health Technologies
Director Trades
Directors Trades: These directos are selling millions to make way for the instos
Private-i
Medtech company Volpara tapped a global network of private investors for its $55m capital raise
Health & Biotech
